Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States, today announced the launch of a new product, Trulieve TruWax. TruWax joins our leading line of concentrates offering patients in Florida a new, rich alternative in Indica, Sativa and Hybrid strains.
Trulieve TruWax is a handcrafted concentrate which is an aromatic, clay-like full-spectrum concentrate that retains the flavor, cannabinoids, terpenes, and resulting effects from the strain it was derived from. TruWax was developed for use with the Trulieve Concentrate Pen or the PuffCo Plus. Similar to the process to create Shatter and TruCRMBL, TruWax is created using a labor-intensive process resulting in a handcrafted, artisanal product that results in a slightly fuller spectrum of relief and aroma.
“We are extremely pleased to add TruWax to our growing list of new, innovative product launches,” said Valda Coryat, Chief Marketing Officer. “Our team has been focused not only on providing new ways for our patients to safely access Trulieve’s products in a COVID-19 environment, but also continuing to deliver new product forms that enhance our patients treatment experience as they manage their specific medical conditions. The full spectrum cannabis oil derived TruWax joins our other recent innovative product launches such as TruPowder and TruTincture drops which are similar to lozenges.”
TruWax is recommended for patients seeking a full-spectrum product that retains the effects of the strain without directly smoking flower.
Trulieve TruWax is currently available in Trulieve’s 46 Florida dispensaries via online ordering for delivery or pick up in-store or curbside.
Trulieve is a vertically integrated “seed-to-sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.